Key benchmark indices were trading in a narrow range in negative terrain in afternoon trade. At 13:20 IST, the barometer index, the S&P BSE Sensex, fell 67.64 points or 0.20% at 34,375.55. The Nifty 50 index declined 22.20 points or 0.21% at 10,614.80.
The Sensex had hit a record high in early trade. Later, the movement of key indices was confined to a narrow range around the flat line till mid-morning trade before extending losses amid weakness in Asian stocks. Key indices pared losses and were hovering in narrow range in negative terrain in afternoon trade.
Among secondary indices, the S&P BSE Mid-Cap index fell 0.46%. The S&P BSE Small-Cap index also dropped 0.25%. Both these indices underperformed the Sensex.
Back home, the breadth, indicating the overall health of the market, was negative. On the BSE, 1,629 shares declined and 1,177 shares advanced. A total of 122 shares were unchanged.
Retail stocks were in demand as investors' sentiment towards the sector improved after media reports sugggested that the Union Cabinet today, 10 January 2018, approved 100% foreign direct investment (FDI) through automatic route in single-brand retail. Future Enterprises (up 5.53%), Provogue (India) (up 4.93%),V-Mart Retail (up 3.94%), V2 Retail (up 3.34%), Shoppers Stop (up 3.14%), Trent (up 2.09%) and Future Retail (up 0.38%), edged higher.
Most pharmaceuticals shares declined. Piramal Enterprises (down 1.41%), Dr Reddy's Laboratories (down 1.08%), Sun Pharmaceutical Industries (down 0.49%), Strides Shasun (down 0.44%), Lupin (down 0.28%), Cadila Healthcare (down 0.26%), GlaxoSmithKline Pharmaceuticals (down 0.22%), Alkem Laboratories (down 0.18%), Divi's Laboratories (down 0.17%), IPCA Laboratories (down 0.15%) and Aurobindo Pharma (down 0.07%), edged lower. Cipla (up 0.68%), Wockhardt (up 0.85%) and Glenmark Pharmaceuticals (up 2.87%), edged higher.
Overseas, Asian stocks were mixed as investors booked profits in shares while oil prices hit three-year highs due to production cuts and a fall in inventories. US equities rose to record highs yesterday, 9 January 2018 as investors remained optimistic about the market heading into the corporate earnings season.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
